Search Results - Moretti, Paul A B
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism by Pitman, Melissa R., Lewis, Alexander C., Davies, Lorena T., Moretti, Paul A. B., Anderson, Dovile, Creek, Darren J., Powell, Jason A., Pitson, Stuart M.
Published 2022Text -
6
Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling by Pitson, Stuart M., Xia, Pu, Leclercq, Tamara M., Moretti, Paul A.B., Zebol, Julia R., Lynn, Helen E., Wattenberg, Binks W., Vadas, Mathew A.
Published 2005Text -
7
-
8
-
9
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress by Wallington-Beddoe, Craig T., Bennett, Melissa K., Vandyke, Kate, Davies, Lorena, Zebol, Julia R., Moretti, Paul A.B., Pitman, Melissa R., Hewett, Duncan R., Zannettino, Andrew C.W., Pitson, Stuart M
Published 2017Text -
10
CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1 by Zhu, Wenying, Gliddon, Briony L., Jarman, Kate E., Moretti, Paul A. B., Tin, Teresa, Parise, Leslie V., Woodcock, Joanna M., Powell, Jason A., Ruszkiewicz, Andrew, Pitman, Melissa R., Pitson, Stuart M.
Published 2016Text -
11
A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties by Pitman, Melissa R., Powell, Jason A., Coolen, Carl, Moretti, Paul A.B., Zebol, Julia R., Pham, Duyen H., Finnie, John W., Don, Anthony S., Ebert, Lisa M., Bonder, Claudine S., Gliddon, Briony L., Pitson, Stuart M.
Published 2015Text -
12
Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody by Tvorogov, Denis, Thompson‐Peach, Chloe A L, Foßelteder, Johannes, Dottore, Mara, Stomski, Frank, Onnesha, Suraiya A, Lim, Kelly, Moretti, Paul A B, Pitson, Stuart M, Ross, David M, Reinisch, Andreas, Thomas, Daniel, Lopez, Angel F
Published 2022Text -
13
An oncogenic role for sphingosine kinase 2 by Neubauer, Heidi A., Pham, Duyen H., Zebol, Julia R., Moretti, Paul A.B., Peterson, Amanda L., Leclercq, Tamara M., Chan, Huasheng, Powell, Jason A., Pitman, Melissa R., Samuel, Michael S., Bonder, Claudine S., Creek, Darren J., Gliddon, Briony L., Pitson, Stuart M.
Published 2016Text -
14
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma by Neubauer, Heidi A., Tea, Melinda N., Zebol, Julia R., Gliddon, Briony L., Stefanidis, Cassandra, Moretti, Paul A. B., Pitman, Melissa R., Costabile, Maurizio, Kular, Jasreen, Stringer, Brett W., Day, Bryan W., Samuel, Michael S., Bonder, Claudine S., Powell, Jason A., Pitson, Stuart M.
Published 2018Text -
15
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia by Powell, Jason A., Lewis, Alexander C., Zhu, Wenying, Toubia, John, Pitman, Melissa R., Wallington-Beddoe, Craig T., Moretti, Paul A. B., Iarossi, Diana, Samaraweera, Saumya E., Cummings, Nik, Ramshaw, Hayley S., Thomas, Daniel, Wei, Andrew H., Lopez, Angel F., D’Andrea, Richard J., Lewis, Ian D., Pitson, Stuart M.
Published 2017Text